We are analyzing https://link.springer.com/article/10.1007/s13277-013-0708-0.

Title:
Expression and regulatory function of miRNA-182 in triple-negative breast cancer cells through its targeting of profilin 1 | Tumor Biology
Description:
We aimed to evaluate the expression of microRNA-182 (miR-182) in triple-negative breast cancer (TNBC) tissues and the TNBC cell line MDA-MB-231 and to investigate the effects of mirR-182 on the cellular behavior of MDA-MB-231 and the expression of the target gene profilin 1 (PFN1), thus providing new methods and new strategies for the treatment of TNBC. Quantitative real-time PCR (qRT-PCR) was utilized to evaluate the expression of miR-182 in TNBC tissues, relatively normal tissues adjacent to TNBC and the TNBC cell line MDA-MB-231. Forty-eight hours after the MDA-MB-231 cells were transfected with the miR-182 inhibitor, qRT-PCR was utilized to detect the changes in miR-182 expression levels, and an MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay was utilized to determine the effects of miR-182 on cell viability. Flow cytometry was adopted to determine whether miR-182 affects the proliferation rates and apoptosis levels of the MDA-MB-231 cells. The transwell migration assay method was used to investigate the effects of miR-182 on the migration of the MDA-MB-231 cells. A luciferase reporter gene system was applied to validate that PFN1 was the target gene of miR-182. Western blot was used to measure the effects of miR-182 on the PFN1 protein expression levels in the cells. qRT-PCR results showed that compared with the relatively normal tissues adjacent to TNBC, miR-182 expression was significantly increased in the TNBC tissues and the MDA-MB-231 cells (p < 0.01). Compared with the control group, MDA-MB-231 cells transfected with the miR-182 inhibitor and incubated for 48 h showed significantly decreased miR-182 expression (p < 0.01). The results of an MTT assay showed that inhibition of miR-182 in MDA-MB-231 cells led to significantly reduced cell viability (p < 0.05). Flow cytometry analysis indicated that inhibition of miR-182 expression resulted in significantly decreased cell proliferation (p < 0.05) and significantly increased levels of apoptosis (p < 0.05). The results of a transwell migration assay showed that after inhibited of miR-182 expression, the number of cells passing through the transwell membranes was significantly decreased (p < 0.05). The results from a luciferase reporter gene system showed that compared with the control group, the relative luciferase activity of the group transfected with the miR-182 inhibitor was significantly increased (p < 0.05). Western blot analysis showed that compared with the control group, PFN1 protein expression levels were significantly increased in the MDA-MB-231 cells transfected with the miR-182 inhibitor and incubated for 48 h (p < 0.05). In conclusion, miR-182 is upregulated in TNBC tissues and cells. It promotes the proliferation and invasion of MDA-MB-231 cells and could negatively regulate PFN1 protein expression. Treatment strategies utilizing inhibition of miR-182 expression or overexpression of the PFN1 gene might benefit patients with TNBC.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Health & Fitness
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We find it hard to spot revenue streams.

Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Link.springer.com could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

cancer, article, google, scholar, pubmed, cas, breast, expression, cells, cell, mdamb, liu, tnbc, triplenegative, microrna, micrornas, wang, tissues, significantly, gene, pfn, profilin, showed, hospital, privacy, cookies, content, xin, effects, levels, proliferation, protein, results, access, oncol, biol, information, publish, research, search, tumor, mirna, targeting, transfected, inhibitor, assay, viability, migration, compared, increased,

Topics {✒️}

month download article/chapter triple-negative breast cancer dicer-independent microrna biogenesis xi-ru li vaccinia virus glv-1h153 yi-qiong zheng quantitative real-time pcr mda-mb-231 cells led high-risk bladder cancer mda-mb-231 cells transfected tumor suppressor qrt-pcr results showed bmc syst biol full article pdf human gastric adenocarcinoma cancer specific survival privacy choices/manage cookies cancer metastasis rev regulate cell survival breast cancer manifested mda-mb-231 cells target gene reis-filho js transl cancer res cancer stem cells relative luciferase activity colorectal cancer screening cancer biother radiopharm nuclear polymeric actin curr opin urol biochem cell biol suppresses cell growth nat cell biol mol cell proteomics transl gastrointest cancer lung cancer mtt assay showed mir-182 expression levels european economic area anti-her2 therapies optimising therapeutic outcomes emerging reciprocal relationship circadian clock modulator genomics proteomics bioinformatics segura mf early mammalian embryogenesis mir-182 expression resulted mir-18a expression normal tissues adjacent conditions privacy policy

Questions {❓}

Bevacizumab: where do we go from here in breast cancer?
Profilins: mimickers of allergy or relevant allergens?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Expression and regulatory function of miRNA-182 in triple-negative breast cancer cells through its targeting of profilin 1
         description:We aimed to evaluate the expression of microRNA-182 (miR-182) in triple-negative breast cancer (TNBC) tissues and the TNBC cell line MDA-MB-231 and to investigate the effects of mirR-182 on the cellular behavior of MDA-MB-231 and the expression of the target gene profilin 1 (PFN1), thus providing new methods and new strategies for the treatment of TNBC. Quantitative real-time PCR (qRT-PCR) was utilized to evaluate the expression of miR-182 in TNBC tissues, relatively normal tissues adjacent to TNBC and the TNBC cell line MDA-MB-231. Forty-eight hours after the MDA-MB-231 cells were transfected with the miR-182 inhibitor, qRT-PCR was utilized to detect the changes in miR-182 expression levels, and an MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay was utilized to determine the effects of miR-182 on cell viability. Flow cytometry was adopted to determine whether miR-182 affects the proliferation rates and apoptosis levels of the MDA-MB-231 cells. The transwell migration assay method was used to investigate the effects of miR-182 on the migration of the MDA-MB-231 cells. A luciferase reporter gene system was applied to validate that PFN1 was the target gene of miR-182. Western blot was used to measure the effects of miR-182 on the PFN1 protein expression levels in the cells. qRT-PCR results showed that compared with the relatively normal tissues adjacent to TNBC, miR-182 expression was significantly increased in the TNBC tissues and the MDA-MB-231 cells (p < 0.01). Compared with the control group, MDA-MB-231 cells transfected with the miR-182 inhibitor and incubated for 48 h showed significantly decreased miR-182 expression (p < 0.01). The results of an MTT assay showed that inhibition of miR-182 in MDA-MB-231 cells led to significantly reduced cell viability (p < 0.05). Flow cytometry analysis indicated that inhibition of miR-182 expression resulted in significantly decreased cell proliferation (p < 0.05) and significantly increased levels of apoptosis (p < 0.05). The results of a transwell migration assay showed that after inhibited of miR-182 expression, the number of cells passing through the transwell membranes was significantly decreased (p < 0.05). The results from a luciferase reporter gene system showed that compared with the control group, the relative luciferase activity of the group transfected with the miR-182 inhibitor was significantly increased (p < 0.05). Western blot analysis showed that compared with the control group, PFN1 protein expression levels were significantly increased in the MDA-MB-231 cells transfected with the miR-182 inhibitor and incubated for 48 h (p < 0.05). In conclusion, miR-182 is upregulated in TNBC tissues and cells. It promotes the proliferation and invasion of MDA-MB-231 cells and could negatively regulate PFN1 protein expression. Treatment strategies utilizing inhibition of miR-182 expression or overexpression of the PFN1 gene might benefit patients with TNBC.
         datePublished:2013-02-22T00:00:00Z
         dateModified:2013-02-22T00:00:00Z
         pageStart:1713
         pageEnd:1722
         sameAs:https://doi.org/10.1007/s13277-013-0708-0
         keywords:
            Triple-negative breast cancer
            MicroRNA-182
             PFN1 gene
            Cancer Research
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-013-0708-0/MediaObjects/13277_2013_708_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-013-0708-0/MediaObjects/13277_2013_708_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-013-0708-0/MediaObjects/13277_2013_708_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-013-0708-0/MediaObjects/13277_2013_708_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-013-0708-0/MediaObjects/13277_2013_708_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-013-0708-0/MediaObjects/13277_2013_708_Fig6_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-013-0708-0/MediaObjects/13277_2013_708_Fig7_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-013-0708-0/MediaObjects/13277_2013_708_Fig8_HTML.gif
         isPartOf:
            name:Tumor Biology
            issn:
               1423-0380
               1010-4283
            volumeNumber:34
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Netherlands
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Hailing Liu
               affiliation:
                     name:General Hospital of Chinese People’s Liberation Army (301 Hospital)
                     address:
                        name:Division of Breast Surgery, Department of General Surgery, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yan Wang
               affiliation:
                     name:General Hospital of Chinese People’s Liberation Army (301 Hospital)
                     address:
                        name:Division of Breast Surgery, Department of General Surgery, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xin Li
               affiliation:
                     name:General Hospital of Chinese People’s Liberation Army (301 Hospital)
                     address:
                        name:Department of Endocrinology, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yan-jun Zhang
               affiliation:
                     name:General Hospital of Chinese People’s Liberation Army (301 Hospital)
                     address:
                        name:Division of Breast Surgery, Department of General Surgery, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jie Li
               affiliation:
                     name:General Hospital of Chinese People’s Liberation Army (301 Hospital)
                     address:
                        name:Division of Breast Surgery, Department of General Surgery, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yi-qiong Zheng
               affiliation:
                     name:General Hospital of Chinese People’s Liberation Army (301 Hospital)
                     address:
                        name:Division of Breast Surgery, Department of General Surgery, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mei Liu
               affiliation:
                     name:General Hospital of Chinese People’s Liberation Army (301 Hospital)
                     address:
                        name:Department of Pathology, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xin Song
               affiliation:
                     name:General Hospital of Chinese People’s Liberation Army (301 Hospital)
                     address:
                        name:Department of Pathology, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xi-ru Li
               affiliation:
                     name:General Hospital of Chinese People’s Liberation Army (301 Hospital)
                     address:
                        name:Division of Breast Surgery, Department of General Surgery, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Expression and regulatory function of miRNA-182 in triple-negative breast cancer cells through its targeting of profilin 1
      description:We aimed to evaluate the expression of microRNA-182 (miR-182) in triple-negative breast cancer (TNBC) tissues and the TNBC cell line MDA-MB-231 and to investigate the effects of mirR-182 on the cellular behavior of MDA-MB-231 and the expression of the target gene profilin 1 (PFN1), thus providing new methods and new strategies for the treatment of TNBC. Quantitative real-time PCR (qRT-PCR) was utilized to evaluate the expression of miR-182 in TNBC tissues, relatively normal tissues adjacent to TNBC and the TNBC cell line MDA-MB-231. Forty-eight hours after the MDA-MB-231 cells were transfected with the miR-182 inhibitor, qRT-PCR was utilized to detect the changes in miR-182 expression levels, and an MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay was utilized to determine the effects of miR-182 on cell viability. Flow cytometry was adopted to determine whether miR-182 affects the proliferation rates and apoptosis levels of the MDA-MB-231 cells. The transwell migration assay method was used to investigate the effects of miR-182 on the migration of the MDA-MB-231 cells. A luciferase reporter gene system was applied to validate that PFN1 was the target gene of miR-182. Western blot was used to measure the effects of miR-182 on the PFN1 protein expression levels in the cells. qRT-PCR results showed that compared with the relatively normal tissues adjacent to TNBC, miR-182 expression was significantly increased in the TNBC tissues and the MDA-MB-231 cells (p < 0.01). Compared with the control group, MDA-MB-231 cells transfected with the miR-182 inhibitor and incubated for 48 h showed significantly decreased miR-182 expression (p < 0.01). The results of an MTT assay showed that inhibition of miR-182 in MDA-MB-231 cells led to significantly reduced cell viability (p < 0.05). Flow cytometry analysis indicated that inhibition of miR-182 expression resulted in significantly decreased cell proliferation (p < 0.05) and significantly increased levels of apoptosis (p < 0.05). The results of a transwell migration assay showed that after inhibited of miR-182 expression, the number of cells passing through the transwell membranes was significantly decreased (p < 0.05). The results from a luciferase reporter gene system showed that compared with the control group, the relative luciferase activity of the group transfected with the miR-182 inhibitor was significantly increased (p < 0.05). Western blot analysis showed that compared with the control group, PFN1 protein expression levels were significantly increased in the MDA-MB-231 cells transfected with the miR-182 inhibitor and incubated for 48 h (p < 0.05). In conclusion, miR-182 is upregulated in TNBC tissues and cells. It promotes the proliferation and invasion of MDA-MB-231 cells and could negatively regulate PFN1 protein expression. Treatment strategies utilizing inhibition of miR-182 expression or overexpression of the PFN1 gene might benefit patients with TNBC.
      datePublished:2013-02-22T00:00:00Z
      dateModified:2013-02-22T00:00:00Z
      pageStart:1713
      pageEnd:1722
      sameAs:https://doi.org/10.1007/s13277-013-0708-0
      keywords:
         Triple-negative breast cancer
         MicroRNA-182
          PFN1 gene
         Cancer Research
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-013-0708-0/MediaObjects/13277_2013_708_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-013-0708-0/MediaObjects/13277_2013_708_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-013-0708-0/MediaObjects/13277_2013_708_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-013-0708-0/MediaObjects/13277_2013_708_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-013-0708-0/MediaObjects/13277_2013_708_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-013-0708-0/MediaObjects/13277_2013_708_Fig6_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-013-0708-0/MediaObjects/13277_2013_708_Fig7_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-013-0708-0/MediaObjects/13277_2013_708_Fig8_HTML.gif
      isPartOf:
         name:Tumor Biology
         issn:
            1423-0380
            1010-4283
         volumeNumber:34
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Netherlands
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Hailing Liu
            affiliation:
                  name:General Hospital of Chinese People’s Liberation Army (301 Hospital)
                  address:
                     name:Division of Breast Surgery, Department of General Surgery, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yan Wang
            affiliation:
                  name:General Hospital of Chinese People’s Liberation Army (301 Hospital)
                  address:
                     name:Division of Breast Surgery, Department of General Surgery, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xin Li
            affiliation:
                  name:General Hospital of Chinese People’s Liberation Army (301 Hospital)
                  address:
                     name:Department of Endocrinology, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yan-jun Zhang
            affiliation:
                  name:General Hospital of Chinese People’s Liberation Army (301 Hospital)
                  address:
                     name:Division of Breast Surgery, Department of General Surgery, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jie Li
            affiliation:
                  name:General Hospital of Chinese People’s Liberation Army (301 Hospital)
                  address:
                     name:Division of Breast Surgery, Department of General Surgery, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yi-qiong Zheng
            affiliation:
                  name:General Hospital of Chinese People’s Liberation Army (301 Hospital)
                  address:
                     name:Division of Breast Surgery, Department of General Surgery, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mei Liu
            affiliation:
                  name:General Hospital of Chinese People’s Liberation Army (301 Hospital)
                  address:
                     name:Department of Pathology, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xin Song
            affiliation:
                  name:General Hospital of Chinese People’s Liberation Army (301 Hospital)
                  address:
                     name:Department of Pathology, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xi-ru Li
            affiliation:
                  name:General Hospital of Chinese People’s Liberation Army (301 Hospital)
                  address:
                     name:Division of Breast Surgery, Department of General Surgery, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Tumor Biology
      issn:
         1423-0380
         1010-4283
      volumeNumber:34
Organization:
      name:Springer Netherlands
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:General Hospital of Chinese People’s Liberation Army (301 Hospital)
      address:
         name:Division of Breast Surgery, Department of General Surgery, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, People’s Republic of China
         type:PostalAddress
      name:General Hospital of Chinese People’s Liberation Army (301 Hospital)
      address:
         name:Division of Breast Surgery, Department of General Surgery, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, People’s Republic of China
         type:PostalAddress
      name:General Hospital of Chinese People’s Liberation Army (301 Hospital)
      address:
         name:Department of Endocrinology, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, China
         type:PostalAddress
      name:General Hospital of Chinese People’s Liberation Army (301 Hospital)
      address:
         name:Division of Breast Surgery, Department of General Surgery, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, People’s Republic of China
         type:PostalAddress
      name:General Hospital of Chinese People’s Liberation Army (301 Hospital)
      address:
         name:Division of Breast Surgery, Department of General Surgery, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, People’s Republic of China
         type:PostalAddress
      name:General Hospital of Chinese People’s Liberation Army (301 Hospital)
      address:
         name:Division of Breast Surgery, Department of General Surgery, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, People’s Republic of China
         type:PostalAddress
      name:General Hospital of Chinese People’s Liberation Army (301 Hospital)
      address:
         name:Department of Pathology, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, China
         type:PostalAddress
      name:General Hospital of Chinese People’s Liberation Army (301 Hospital)
      address:
         name:Department of Pathology, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, China
         type:PostalAddress
      name:General Hospital of Chinese People’s Liberation Army (301 Hospital)
      address:
         name:Division of Breast Surgery, Department of General Surgery, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, People’s Republic of China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Hailing Liu
      affiliation:
            name:General Hospital of Chinese People’s Liberation Army (301 Hospital)
            address:
               name:Division of Breast Surgery, Department of General Surgery, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Yan Wang
      affiliation:
            name:General Hospital of Chinese People’s Liberation Army (301 Hospital)
            address:
               name:Division of Breast Surgery, Department of General Surgery, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Xin Li
      affiliation:
            name:General Hospital of Chinese People’s Liberation Army (301 Hospital)
            address:
               name:Department of Endocrinology, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, China
               type:PostalAddress
            type:Organization
      name:Yan-jun Zhang
      affiliation:
            name:General Hospital of Chinese People’s Liberation Army (301 Hospital)
            address:
               name:Division of Breast Surgery, Department of General Surgery, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Jie Li
      affiliation:
            name:General Hospital of Chinese People’s Liberation Army (301 Hospital)
            address:
               name:Division of Breast Surgery, Department of General Surgery, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Yi-qiong Zheng
      affiliation:
            name:General Hospital of Chinese People’s Liberation Army (301 Hospital)
            address:
               name:Division of Breast Surgery, Department of General Surgery, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Mei Liu
      affiliation:
            name:General Hospital of Chinese People’s Liberation Army (301 Hospital)
            address:
               name:Department of Pathology, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, China
               type:PostalAddress
            type:Organization
      name:Xin Song
      affiliation:
            name:General Hospital of Chinese People’s Liberation Army (301 Hospital)
            address:
               name:Department of Pathology, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, China
               type:PostalAddress
            type:Organization
      name:Xi-ru Li
      affiliation:
            name:General Hospital of Chinese People’s Liberation Army (301 Hospital)
            address:
               name:Division of Breast Surgery, Department of General Surgery, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, People’s Republic of China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Division of Breast Surgery, Department of General Surgery, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, People’s Republic of China
      name:Division of Breast Surgery, Department of General Surgery, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, People’s Republic of China
      name:Department of Endocrinology, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, China
      name:Division of Breast Surgery, Department of General Surgery, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, People’s Republic of China
      name:Division of Breast Surgery, Department of General Surgery, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, People’s Republic of China
      name:Division of Breast Surgery, Department of General Surgery, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, People’s Republic of China
      name:Department of Pathology, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, China
      name:Department of Pathology, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, China
      name:Division of Breast Surgery, Department of General Surgery, General Hospital of Chinese People’s Liberation Army (301 Hospital), Beijing, People’s Republic of China
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(134)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

3.9s.

LINK . SPRINGER . COM {}